J Kevin Buchi

J Kevin Buchi has an estimated net worth of $9.36 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, TETRALOGIC PHARMACEUTICALS Corp, ZIOPHARM ONCOLOGY INC, Alexza Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Benitec Biopharma Inc., Ampio Pharmaceuticals, Inc., CEPHALON INC, BIOSPECIFICS TECHNOLOGIES CORP, EPIRUS Biopharmaceuticals, Inc., Impax Laboratories, LLC, STEMLINE THERAPEUTICS INC, and ENCYSIVE PHARMACEUTICALS INC.

2006 was J Kevin Buchi's most active year for acquiring shares with 10 total transactions. J Kevin Buchi's most active month to acquire stocks was the month of November. 2011 was J Kevin Buchi's most active year for disposing of shares, totalling 25 transactions. J Kevin Buchi's most active month to dispose stocks was the month of November. 2013 saw J Kevin Buchi paying a total of $3,174,278.00 for 473,254 shares, this is the most they've acquired in one year. In 2006 J Kevin Buchi cashed out on 90,944 shares for a total of $4,584,803.18, their largest year based on trade value.